Últimas noticias sobre Korro Bio (NASDAQ:KRRO) Bolsa

KORRO BIO INC

Korro Bio

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Korro Bio Inc

Barclays analyst Brandt Montour maintains Ballys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALY#NYSE">BALY</a>) with a Equal-Weight and lowers the price target from $14 to $13.

News

Price Target

Analyst Ratings

BALY

Barclays Maintains Equal-Weight on Ballys, Lowers Price Target to $13

<a href="https://www.whitehouse.gov/fact-sheets/2025/05/fact-sheet-president-donald-j-trump-secures-historic-600-billion-investment-commitment-in-saudi-arabia/" title="https://www.whitehouse.gov/fact-sheets/2025/05/fact-sheet-president-donald-j-trump-secures-historic-600-billion-investment-commitment-in-saudi-arabia/">https://www.whitehouse.gov/fact-sheets/2025/05/fact-sheet-president-donald-j-trump-secures-historic-600-billion-investment-commitment-in-saudi-arabia/</a>

Government

Macro Economic Events

Politics

Economics

General

Partnerships Include $5B Energy Investment Fund, $5B New Era Aerospace And Defense Technology Fund, $4B Enfield Sports Global Sports Fund

Shamekh IV Solutions To Invest $5.8B Including Michigan Plant To Launch High-Capacity IV Fluid Facility

Mizuho analyst Nitin Kumar maintains Devon Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>) with a Outperform and lowers the price target from $46 to $43.

Mizuho Maintains Outperform on Devon Energy, Lowers Price Target to $43

HUMAIN, the new full AI value chain subsidiary of Saudi Arabia's Public Investment Fund, today announced a landmark strategic partnership with NVIDIA, the world leader in AI computing infrastructure, to drive the next wave of artificial intelligence development.
The two organizations will leverage NVIDIA platforms and expertise to establish Saudi Arabia as a global leader in AI, GPU cloud computing and digital transformation to drive innovation and growth worldwide.
The partnership underscores HUMAIN's mission to position Saudi Arabia as an international AI powerhouse — combining cutting-edge infrastructure, frontier AI models, immersive digital platforms and human capital development.
Powering AI Factories of Tomorrow
HUMAIN is making a major investment to build AI factories in the Kingdom of Saudi Arabia with a projected capacity of up to 500 megawatts powered by several hundred thousand of NVIDIA's most advanced GPUs over the next five years. The first phase of deployment will be an 18,000 NVIDIA GB300 Grace Blackwell AI supercomputer with NVIDIA InfiniBand networking.

NVDA

HUMAIN Announces Strategic Partnership With NVIDIA To Drive Next Wave Of Artificial Intelligence Development

Macro Notification

Hill International, Jacobs, Parsons, And AECOM To Build Infrastructure Projects Like King Salman International Airport, King Salman Park, The Vault, Qiddiya City And More Totaling $2B In U.S. Service Exports; Major Exports Include GE Vernova's Gas Turbines And Energy Solutions Totaling $14.2B And Boeing 737-8 Aircraft For AviLease Totaling $4.8B

Leerink Partners downgrades Halozyme Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HALO#NASDAQ">HALO</a>) from Market Perform to Underperform and announces $47 price target.

Downgrades

HALO

Leerink Partners Downgrades Halozyme Therapeutics to Underperform, Announces $47 Price Target

Raymond James analyst Simon Leopold initiates coverage on Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) with a Outperform rating and announces Price Target of $41.

Initiation

SMCI

Raymond James Initiates Coverage On Super Micro Computer with Outperform Rating, Announces Price Target of $41

Rep. Alexandria Ocasio-Cortez (D-NY) is calling out the Trump administration for what she described as a massive financial windfall for private prison companies running immigration detention centers, including the recently reopened Delaney Hall in Newark, New Jersey.
<h2 class="wp-block-heading">Private Prison Profits and Political Connections&nbsp;</h2>
The progressive lawmaker took to <a href="https://www.instagram.com/reel/DJfpuCXsK6p/">Instagram Live</a> on Sunday to highlight concerns over the facility's permits and the influence of political donations.
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
&#8220;There is a dispute over, a lot of people don&#8217;t know, like the reason that this altercation even happened is because that facility, I don&#8217;t even believe has a certificate, has not even been given a certificate of occupancy by the city of Newark yet,&#8221; Ocasio-Cortez said. &#8220;And so there&#8217;s a dispute, I believe, over whether that facility even has the proper clearances to even open or operate.&#8221;
Ocasio-Cortez also called out the companies behind these facilities, including CoreCivic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXW#NYSE">CXW</a>) and GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>), accusing them of prioritizing profits over humane conditions for detainees.&nbsp;
&#8220;These are private prison companies, for-profit corporations. And that is the reason why the conditions in a lot of these detention facilities are so horrible,&#8221; she said. &#8220;It&#8217;s not because of some like, oh, you know, any sort of federal law. It&#8217;s the opposite. It&#8217;s because the Trump administration is funneling money to private prison companies.&#8221;
Trending: Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a>
She noted that these companies have <a href="https://www.benzinga.com/general/politics/24/11/41779902/prison-stocks-geo-group-corecivic-rally-on-trump-2024-election-win-history-shows-the-gains-may-n">financially benefited since the election</a>. &#8220;This is what it&#8217;s all about,&#8221; she said. &#8220;You can literally look up the stock prices for GeoGroup and CoreCivic and look at their stock prices since the election.&#8221;&nbsp;
GEO Group&#8217;s stock has surged from $15.13 on Nov. 5 to $26.48 on Nov. 11, while CoreCivic&#8217;s climbed from $13.63 to $23.94 over the same period.
<h2 class="wp-block-heading">Newark Mayor Arrested During Protest</h2>
The controversy over Delaney Hall escalated on Friday when Newark Mayor Ras Baraka, a Democrat who is running for governor, was arrested outside the facility. Federal prosecutors charged Baraka with trespassing after he reportedly ignored warnings from federal agents, Alina Habba, interim U.S. attorney for New Jersey, <a href="https://x.com/AlinaHabba/status/1920918181951971563">posted</a> on X.
Baraka, who has been a vocal critic of the facility, was accompanied by three New Jersey congressional Democrats — Reps. LaMonica McIver, Bonnie Watson Coleman, and Robert Menendez Jr. — during the protest.&nbsp;
See Also: Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — don't repeat history — <a href="https://www.benzinga.com/money/big-tech-has-spent-billions-acquiring-ai-smart-home-startups-one-company-stands-to-benefit-and-has-already-made-10-million">invest in RYSE at just $1.90/share</a>.
The lawmakers said they were at the site to inspect conditions but were met with resistance from federal agents. &#8220;We were able to get in, speak to detainees, check out the facilities, and make sure everything was OK there,&#8221; McIver told <a href="https://www.youtube.com/watch?v=Ewg2we9qq-o">CNN</a>. &#8220;But ICE kept giving us the run-around,&#8221; added Watson Coleman.
Baraka was booked and released the same day. In a video reviewed by the <a href="https://apnews.com/article/newark-immigration-baraka-ice-arrest-c260a4f0fda53ec52bca691a1f68aeda">Associated Press</a>, a federal official can be heard telling Baraka that he could not enter the facility because he was &#8220;not a congress member.&#8221;
DHS has maintained that the facility has the necessary permits and completed all required inspections, despite Baraka's claims to the contrary, according to the AP.
Read Next:
<ul class="wp-block-list">
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

'Trump Administration Funneling Money To Private Prison Companies' AOC Says, Calling Out Profits From ICE Detentions After Campaign Kickbacks

Mizuho analyst Nitin Kumar maintains Coterra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>) with a Outperform and lowers the price target from $38 to $36.

CTRA

Mizuho Maintains Outperform on Coterra Energy, Lowers Price Target to $36

GOOG

GOOGL

ORCL

UBER

President Trump Announced Saudi Arabia's $600B Commitment To Invest In U.S.; DataVolt To Invest $20B In AI Data Centers And Energy Infrastructure In U.S.; Google, DataVolt, Oracle, Salesforce, AMD And Uber To Invest $80B

Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) has outperformed the market over the past 10 years by 2.0% on an annualized basis producing an average annual return of 12.63%. Currently, Aflac has a market capitalization of $57.26 billion. 
Buying $1000 In AFL: If an investor had bought $1000 of AFL stock 10 years ago, it would be worth $3,302.05 today based on a price of $105.55 for AFL at the time of writing.
<h3>Aflac's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747145722_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

Mizuho analyst Nitin Kumar maintains Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) with a Neutral and lowers the price target from $129 to $124.

Mizuho Maintains Neutral on Exxon Mobil, Lowers Price Target to $124

President Donald Trump is advancing a series of executive orders aimed at dramatically reshaping U.S. nuclear energy policy to accelerate the construction of new nuclear power plants and reduce regulatory barriers. Several companies in the nuclear energy sector could benefit from accelerated expansion <a href="https://www.benzinga.com/news/25/05/45337965/google-to-fund-three-nuclear-sites-says-the-move-will-allow-them-to-move-at-the-speed-required-to-meet-this-moment-of-ai-and-american-innovation">of the industry.&nbsp;</a>
The Details: The Trump administration's draft executive orders are intended to quadruple U.S. nuclear power production by 2050, increasing capacity from about 100 gigawatts to 400 gigawatts,<a href="https://www.nytimes.com/2025/05/09/climate/trump-draft-nuclear-executive-orders.html"> according</a> to the New York Times.&nbsp;
Read Next: <a href="https://www.benzinga.com/25/05/45354683/tesla-probably-wont-make-money-on-ride-hailing-for-years-gary-black-says?utm_source=articleShare">Tesla Robotaxi Hopes Dashed By Uber, Lyft: No Fast Lane To Profits, Warns Investor Gary Black&nbsp;</a>
The orders cite the need to catch up with China and Russia, which have recently dominated new nuclear reactor deployments. Trump also aims to rebuild domestic uranium and nuclear fuel supply chains and reduce reliance on Russian and Chinese imports.&nbsp;
Stocks To Watch: Companies directly involved in nuclear power generation, uranium mining and enrichment as well as advanced reactor technology, stand to benefit from an acceleration in construction and deregulation of the nuclear energy industry. 
Constellation Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) and Vistra Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) are major utility companies with nuclear assets and are well-positioned to benefit from streamlined regulations and a supportive policy environment.&nbsp;
Oklo, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>), which is focused on small modular reactors (SMR), is gaining traction as Trump's policies favor rapid deployment of advanced nuclear technologies and AI/data center partnerships. 
NuScale Power Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) is another company developing SMR technology and<a href="https://www.benzinga.com/news/earnings/25/05/45361335/nuscale-power-reports-q1-results-details"> is positioned</a> to capitalize on streamlined permitting and increased federal support for advanced nuclear projects.&nbsp;
VanEck Uranium and Nuclear ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLR#NYSE">NLR</a>) provides diversified exposure to leading nuclear utilities, uranium miners and other sector leaders. The ETF could be a lower-risk way to capture upside from the nuclear renaissance.&nbsp;
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/health-care/25/05/45305392/unitedhealth-investors-claim-company-hid-profit-impact-of-ceos-murder?utm_source=articleShare">UnitedHealth Investors Claim Company Hid Profit Impact Of CEO&#8217;s Murder</a>&nbsp;</li>
</ul>
Image: Shutterstock

Large Cap

Regulations

Specialty ETFs

Movers

ETFs

OKLO

Trump Wants To Kickstart Nuclear Development: These 5 Stocks Could Boom

WIIM

GOCO

GOCO stock has given up its prior gain. GoHealth shares were trading higher after the company reported a Q1 revenue beat.

ALZN

ALZN stock has given up its prior gain. Alzamend Neuro shares were trading higher after the company announced it initiated the Phase 2 clinical trial of AL001.

Mizuho analyst Nitin Kumar maintains Occidental Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) with a Neutral and lowers the price target from $60 to $58.

Mizuho Maintains Neutral on Occidental Petroleum, Lowers Price Target to $58

<a href="https://www.cnbc.com/2025/05/13/gm-new-ev-battery-tech.html">https://www.cnbc.com/2025/05/13/gm-new-ev-battery-tech.html</a>

'GM unveils new 'groundbreaking' EV battery tech, aims to be first to market'- CNBC

Mizuho analyst Nitin Kumar maintains Talos Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TALO#NYSE">TALO</a>) with a Outperform and lowers the price target from $12 to $11.

TALO

Mizuho Maintains Outperform on Talos Energy, Lowers Price Target to $11

Leerink Partners analyst David Risinger downgrades Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) from Outperform to Market Perform and lowers the price target from $169 to $153.

Leerink Partners Downgrades Johnson & Johnson to Market Perform, Lowers Price Target to $153

Health Care

Press Releases

Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency

Korro to Participate in Upcoming Investor Conferences

Management

CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors

Korro to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Korro Bio Announces Dosing of First Participants in REWRITE Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update

Korro to Present at the TD Cowen 45th Annual Health Care Conference

KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency

Earnings

Korro Reports Full Year 2024 Financial Results and Provides Business Updates

Korro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific Officer

Korro Reports First Quarter 2025 Financial Results and Provides Business Updates

Comments

Korro Bio

Noticias

Últimas noticias sobre Korro Bio (NASDAQ:KRRO) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL